3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for broad patient populations.
26 employees · est. 2017 · South San Francisco, United...
Greywolf Therapeutics
We are advancing novel antigen modulation technology that controls T cells to guide the immune system.
49 employees · est. 2017 · United Kingdom
Side-by-Side Comparison
| Metric | 3T Biosciences | Greywolf Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2017 |
| Headquarters | ||
| Headquarters | South San Francisco, United States | United Kingdom |
| Employees | ||
| Employees | 26 | 49 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $52.00M | $107.10M |
| Funding Rounds | ||
| Funding Rounds | 3 | 5 |
| Services | ||
| Services | Development of transformative therapies, Treatment for solid tumors, Innovative immunotherapy solutions | Development of antigen modulation technology for therapeutic treatments in oncology, autoimmunity, and virology |
| Target Customers | ||
| Target Customers | Patients with solid tumors, Broad patient populations, Healthcare providers | Patients with cancers, autoimmune disorders, and infectious diseases |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Next-generation Therapies, Transformative Therapies, Solid Tumors, Immune-mediated Diseases, Broad Patient Populations, Cancer Treatment, Immune System Leveraging, Cell-targeting Technology, Safer Cancer Therapies, Effective Cancer Treatments, Curative Therapies, Difficult-to-treat Cancers, Oncology | Biotherapeutics, Immunotherapy, Cancer Treatment, Autoimmune Disorders, Infectious Diseases, T Cell Activation, Antigen Modulation, Clinical Development, Immunology, Therapeutic Innovations |
| Website | ||
| Website | 3tbiosciences.com | greywolftherapeutics.com |
About 3T Biosciences
3T Biosciences, founded in 2017 and headquartered in the United States, is an emerging player in the Biopharma and Biotechnology sectors. The company is dedicated to revolutionizing immunotherapy by developing next-generation therapies aimed at treating solid tumors and other immune-mediated disease...
About Greywolf Therapeutics
Greywolf Therapeutics is a biotechnology startup based in the United Kingdom, founded in 2017. The company is focused on solving immune dysfunction by advancing novel antigen modulation technology that guides the immune system. Their approach addresses the challenge of T cells not being able to reco...
We will tell you when either one moves
BounceWatch watches 3T Biosciences and Greywolf Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at 3T Biosciences and Greywolf Therapeutics — by email.
Frequently Asked Questions
Compare 3T Biosciences with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at 3T Biosciences on 4 Jun 2026, and Greywolf Therapeutics on 25 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
